Your browser doesn't support javascript.
loading
Influence of different chemotherapeutic drugs combined with oxaliplatin on living quality and serum related tumor markers in gastric cancer patients with postoperative recurrence and metastasis / 重庆医学
Chongqing Medicine ; (36): 3795-3797, 2017.
Article in Zh | WPRIM | ID: wpr-661951
Responsible library: WPRO
ABSTRACT
Objective To study the influence of capecitabine or S-1 combined with oxaliplatin on the quality of life and serum tumor marker in gastric cancer patients with postoperative recurrence and metastasis.Methods One hundred and six cases of postoperative recurrence and metastasis treated by gastric cancer radical operation in our hospital from January 2013 to December 2015were selected and divided into the control group and observation group according to the random number table method,53 cases in each group.The control group was given S-1 combined with oxaliplatin treatment,while the experimental group was given capeeitabine combined with oxaliplatin treatment.The clinical efficacy,quality of life,serum related tumor markers and adverse reactions were compared between the two groups.Results The effective rate was 64.15% in the control group and 69.81% in the observation group,the difference was not statistically significant (P<0.05).The improvement rate of the quality of life in the control group was 73.58%,the stability rate was 18.87% and decline rate was 26.42%,the total improvement rate was 73.58%,which in the observation group were 49.06 %,20.75 %,30.19 % and 69.81 % respectively,the differences were not statistically significant (P>0.05).After treatment,the levels of CA50,CA125,CA199 and CEA in the two groups were significantly decreased compared with before treatment (P<0.05),but the serum related tumor markers had no statistically significant difference between the two groups (P>0.05).The common adverse reactions in the two groups included hemoglobin decrease,white blood cell decline,thrombocytopenia,nausea and vomiting,the two groups could be tolerated,the difference was not statistically significant (P>0.05).Conclusion Capecitabine or S-1 combined with oxaliplatin has the same curative effect in treating postoperative recurrence and metastasis after gastric cancer operation,the improvement of quality of life and serum related tumor indicators is similar,and the adverse reactions could be tolerated.
Key words
Full text: 1 Index: WPRIM Language: Zh Journal: Chongqing Medicine Year: 2017 Type: Article
Full text: 1 Index: WPRIM Language: Zh Journal: Chongqing Medicine Year: 2017 Type: Article